Angiodynamics, Inc.
Clinical trials sponsored by Angiodynamics, Inc., explained in plain language.
-
Electric pulses zap liver cancer in promising new trial
Disease control Not yet recruitingThis study looks at a procedure called irreversible electroporation (IRE) for people with liver cancer that hasn't spread. IRE uses electrical pulses to destroy tumor cells without cutting into the liver. The study will include 50 adults with good liver function and up to 3 small…
Phase: NA • Sponsor: Angiodynamics, Inc. • Aim: Disease control
Last updated May 26, 2026 09:04 UTC
-
New device aims to save legs from amputation in artery disease trial
Disease control Not yet recruitingThis study tests whether using a special device (Auryon Atherectomy System) along with standard balloon angioplasty is safer and more effective than balloon angioplasty alone for clearing blockages in the lower leg arteries. About 50 people with severe peripheral artery disease (…
Phase: NA • Sponsor: Angiodynamics, Inc. • Aim: Disease control
Last updated May 26, 2026 09:00 UTC
-
Electric pulses aim to zap liver tumors in colorectal cancer patients
Disease control Not yet recruitingThis study tests a procedure called irreversible electroporation (IRE) for people with colorectal cancer that has spread to the liver. It includes 50 adults who have already had at least one round of chemotherapy. The goal is to see if IRE can destroy the liver tumors without maj…
Phase: NA • Sponsor: Angiodynamics, Inc. • Aim: Disease control
Last updated May 26, 2026 08:53 UTC
-
New suction device could save hearts from deadly infection
Disease control Not yet recruitingThis study tests a device called AngioVac that suctions out infected growths (vegetations) from the right side of the heart in people with a serious heart infection called infective endocarditis. About 30 adults with large growths will be enrolled to see if the procedure is safe …
Phase: NA • Sponsor: Angiodynamics, Inc. • Aim: Disease control
Last updated May 22, 2026 13:53 UTC